Home > Cashflow Statement > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr

What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Investing Activities ratio of NATCO PHARMA is ₹-1,033 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹-1,033 Cr
Mar2023₹-477 Cr
Mar2022₹-5.30 Cr
Mar2021₹-103 Cr
Mar2020₹-167 Cr

How is Cash Flow from Investing Activities of NATCO PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹-1,033 Cr
Negative
Mar2023 ₹-477 Cr
Negative
Mar2022 ₹-5.30 Cr
Negative
Mar2021 ₹-103 Cr
Negative
Mar2020 ₹-167 Cr -

Compare Cash Flow from Investing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,535.1 Cr 7.4% 17.7% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.7% -3.8% -7.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

7.4%

17.7%

-15.5%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses